Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy.
Yamin R, Jones AT, Hoffmann HH, Schäfer A, Kao KS, Francis RL, Sheahan TP, Baric RS, Rice CM, Ravetch JV, Bournazos S.
Yamin R, et al. Among authors: sheahan tp.
Nature. 2021 Nov;599(7885):465-470. doi: 10.1038/s41586-021-04017-w. Epub 2021 Sep 21.
Nature. 2021.
PMID: 34547765
Free PMC article.